Daniel Bertrand

Active 1976–2025

135
Papers
26,511
Citations
92
h-index
132
i10-index

Citations

Citations per year for Daniel Bertrand1977: 1 citations1978: 4 citations1981: 2 citations1982: 3 citations1983: 5 citations1984: 11 citations1985: 13 citations1986: 17 citations1987: 21 citations1988: 23 citations1989: 30 citations1990: 43 citations1991: 51 citations1992: 84 citations1993: 95 citations1994: 116 citations1995: 135 citations1996: 158 citations1997: 189 citations1998: 219 citations1999: 178 citations2000: 223 citations2001: 216 citations2002: 256 citations2003: 203 citations2004: 182 citations2005: 198 citations2006: 210 citations2007: 216 citations2008: 217 citations2009: 213 citations2010: 172 citations2011: 210 citations2012: 223 citations2013: 169 citations2014: 161 citations2015: 182 citations2016: 139 citations2017: 151 citations2018: 81 citations2019: 352 citations2020: 422 citations2021: 351 citations2022: 178 citations2023: 178 citations2024: 233 citations2025: 87 citations2026: 4 citations1979–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,053 citing papers, 34.2% of this breakdownUnited Kingdom: 478 citing papers, 7.9% of this breakdownFrance: 366 citing papers, 6.1% of this breakdownGermany: 364 citing papers, 6.1% of this breakdownChina: 292 citing papers, 4.9% of this breakdownSwitzerland: 233 citing papers, 3.9% of this breakdownAustralia: 230 citing papers, 3.8% of this breakdownItaly: 208 citing papers, 3.5% of this breakdownJapan: 181 citing papers, 3% of this breakdownCanada: 180 citing papers, 3% of this breakdownSweden: 121 citing papers, 2% of this breakdownNetherlands: 97 citing papers, 1.6% of this breakdown
0%34.2%Other 20%

Fields

  • Biochemistry, Genetics and Molecular Biology52.6%
  • Neuroscience23.2%
  • Medicine11.6%
  • Physics and Astronomy2.5%
  • Agricultural and Biological Sciences2.3%
  • Engineering1.5%
  • Other6.3%

Topics

  • Nicotinic Acetylcholine Receptors Study15.5%
  • Receptor Mechanisms and Signaling7.9%
  • Ion channel regulation and function7.4%
  • Neuroscience and Neuropharmacology Research6.7%
  • Hearing, Cochlea, Tinnitus, Genetics3.2%
  • Cholinesterase and Neurodegenerative Diseases3%
  • Other56.3%

Coauthors

All papers

Open in search
  1. Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System

    Authors: , - The Annual Review of Pharmacology and Toxicology 2006 cited by 1,185

  2. Nicotinic acetylcholine receptors: From basic science to therapeutics

    Authors: , , - Pharmacology & Therapeutics 2012 cited by 525

  3. Nicotinic acetylcholine receptors in neurological and psychiatric diseases

    Authors: , , - Pharmacological Research 2023 cited by 81

  4. Nicotinic acetylcholine receptors: from structure to brain function

    Authors: , , - Reviews of physiology, biochemistry and pharmacology 2003 cited by 530

  5. The molecular mechanism of snake short-chain α-neurotoxin binding to muscle-type nicotinic acetylcholine receptors

    Authors: , , , , , , , , , , - Nature Communications 2022 cited by 58

  6. A three-dimensional multi-electrode array for multi-site stimulation and recording in acute brain slices

    Authors: , , , , - Journal of Neuroscience Methods 2002 cited by 282

  7. Evoked Mechanical Responses of Isolated Cochlear Outer Hair Cells

    Authors: , , , - Science 1985 cited by 1,843

  8. First Steps toward Noninvasive Intraocular Pressure Monitoring with a Sensing Contact Lens

    Authors: , , , , - Investigative Ophthalmology & Visual Science 2004 cited by 244

  9. The solithromycin journey—It is all in the chemistry

    Authors: , , , - Bioorganic & Medicinal Chemistry 2016 cited by 97

  10. EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors

    Authors: , , , , , , , , , , , , - Neuropharmacology 2011 cited by 204

  11. Zinc: An underappreciated modulatory factor of brain function

    Authors: , , - Biochemical Pharmacology 2014 cited by 147

  12. A Review of the Cholinergic System and Therapeutic Approaches to Treat Brain Disorders

    Authors: , - Current topics in behavioral neurosciences 2020 cited by 50

  13. Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor

    Authors: , , , , , , , , - Nature 1991 cited by 525

  14. A Novel Positive Allosteric Modulator of the α7 Neuronal Nicotinic Acetylcholine Receptor:In VitroandIn VivoCharacterization

    Authors: , , , , , , , , , , , , , , , - Journal of Neuroscience 2005 cited by 444

  15. CHRNB2 Is the Second Acetylcholine Receptor Subunit Associated with Autosomal Dominant Nocturnal Frontal Lobe Epilepsy*

    Authors: , , , , , , , , , , - The American Journal of Human Genetics 2001 cited by 325

  16. Neuropsychopharmacology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raymond S Hurst, Peter Riederer, Siegfried Hoyer, Wiepke Cahn, Heleen B. M. Boos, H D Postma, R. H. De Rijk, E. R Kloet, Sharon Morein‐Zamir, Barbara J. Sahakian, Peter Riederer, Siegfried Hoyer, J. M. Bessa, Osborne F. X. Almeida, N. Sousa, Wiepke Cahn, Heleen B. M. Boos, H D Postma, R. Andrew Chambers, Caroline Cohen, Marc Turiault, Guy Griebel, Caroline Cohen, Marc Turiault, Guy Griebel, Wolfgang Fleischhacker, Alfonso Abizaid, Shimon Amir, Jaanus Harro, Peter Verheart, Per Svenningsson, Per E. Andrén, R. Andrew Chambers, Kenneth J. Rhodes, A. Richard Green, María Isabel Colado, María Isabel Colado, Richard Green, Christof Baltes, Thomas Mueggler, Markus Rudin, Lucy C. Guillory, Becky Kinkead, Charles B. Nemeroff, Wiepke Cahn, Heleen B. M. Boos, H D Postma, Heleen B. M. Boos, H. D. Postma, Wiepke Cahn, Stephen B. Dunnett, Michael J. Kuhar, Anne M. Andrews, Greg A. Gerhardt, Lynette C. Daws, Stephen M. Stahl, Meghan M. Grady, Jean‐Michel Scherrmann, Arthur Christopoulos, Gregory D. Stewart, Patrick M. Sexton, Jelena Nešić, Theodora Duka, Paul B. S. Clarke, Maxine L. Stitzer, Daniel Bertrand, Hans Rollema, Raymond S Hurst, Hans Rollema, Daniel Bertrand and 37 more - Encyclopedia of Psychopharmacology 2010 cited by 323

  17. Ivermectin: A Positive Allosteric Effector of the α7 Neuronal Nicotinic Acetylcholine Receptor

    Authors: , , , , , , - Molecular Pharmacology 1998 cited by 320

  18. Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor.

    Authors: , , , , - The EMBO Journal 1996 cited by 181

  19. Pentameric ligand-gated ion channel ELIC is activated by GABA and modulated by benzodiazepines

    Authors: , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 129

  20. The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function

    Authors: , , , , , , - Biochemical Pharmacology 2011 cited by 119

  21. Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptor

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 115

  22. Dithiol amino acids can structurally shape and enhance the ligand-binding properties of polypeptides

    Authors: , , , , , , , - Nature Chemistry 2014 cited by 85

  23. A lipid site shapes the agonist response of a pentameric ligand-gated ion channel

    Authors: , , , , , , , , , , , , , , , , - Nature Chemical Biology 2019 cited by 66

  24. Chemogenetics a robust approach to pharmacology and gene therapy

    Authors: , , , , - Biochemical Pharmacology 2020 cited by 31